Thursday, July 26, 2012

Morning Journal - Geithner up to his ears in Libor



Share/Bookmark
Economics

This Week’s Data

June new home sales fell 8.3% versus expectations of a 1.6% increase.
http://www.calculatedriskblog.com/2012/07/new-home-sales-declined-in-june-to.html

Weekly jobless claims fell 33,000 versus estimates of a 6,000 decline; seasonal adjustments continue to heavily influence these numbers.
http://www.calculatedriskblog.com/2012/07/weekly-initial-unemployment-claims_26.html

June durable goods orders rose 1.6% versus forecasts of up 0.6%; however, ex transportation orders, they dropped 1.1% versus an anticipated increase of 0.2%.

Friday, July 20, 2012

Jon Stewart on Libor--Thursday afternoon humor



Share/Bookmark

Thursday, July 19, 2012

Morning Journal--The big four economic indicators



Share/Bookmark
Economics

This Week’s Data

The Fed released its latest Beige Book; and the results are not unexpected nor different from anything Bernanke has been saying in his congressional testimony: retail spending is disappointing but manufacturing, housing, loan demand and sentiment are improving slowly. No hint of the need for QEIII.

Weekly jobless claims rose 36,000 versus estimates of up 15,000.
http://www.calculatedriskblog.com/2012/07/weekly-initial-unemployment-claims_19.html


Tuesday, July 10, 2012

Why JP Morgan and Goldman are liabilities not assets to our financial system



Share/Bookmark
All American Investor

On 14 April 2012, former Goldman Sachs Executive Director Greg Smith recorded a very public and sensational exit interview in the opinion pages of the New York Times.

The letter criticised “toxic and destructive” practices and cultures within Goldman Sachs, one of the world’s largest, most important and influential investment banks. The criticism focused on practices that exploited clients and put the interests of the bank first. It alleged a culture that was focused on getting clients to invest in securities or products that Goldman was interested in getting rid off. The letter highlighted the use of complexity to confuse clients and the focus on highly profitable and (sometimes) unsophisticated clients who did not fully understand the risks of the transactions that they were being encouraged to enter into.

Continue Reading at the Source


Original content Bob DeMarco, All American Investor

Tuesday, July 3, 2012

60 Minutes Glaxo Whistle Blower Bad Medicine (Video, Text)



Share/Bookmark
Of all the things that you trust every day, you want to believe your prescription medicine is safe and effective. The pharmaceutical industry says that it follows the highest standards for quality....

By Bob DeMarco
Alzheimer's Reading Room

I actually received the wrong medication for my mother once. I opened the bottle and the pills were a different color then I was use to seeing. I had the medication for about ten days before I opened the bottle.

When I called to ask about the medication the "tech" on the phone told me the pharmacy bought their drugs from several generic manufacturers and this probably explained the difference. I still felt uneasy.

What's the Relationship Between the Brain and the Soul?



Share/Bookmark
The reason why that's very empowering is because if you are having a tough time in life mired in depression or mired in some negative mood, we're hoping that people read this and say, "I have this amazing partner in my head, this amazing organ, even cooler than my stomach, and it's mine to use."

Alzheimer's Reading Room
Rudy Tanzi
"You're taught that you're born with a certain number of nerve cells, you lose them, and you don't get them back. 

Well, guess what, that's wrong. 

Now we know that new nerve cells are made exactly in the region of the brain where Alzheimer's hits. 

We also know from research in my lab and other labs that if you induce nerve cells to divide in the short-term memory part of the brain, you can improve the symptoms of Alzheimer's disease in animal models." -- Rudy Tanzi, Director, Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease